Miami Cardiology Group — Miami, Florida

Miami Cardiology Group is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Miami Cardiology Group has participated in 2 clinical trials.

Therapeutic areas: Heart Failure, Congestive, Myocardial Infarction, Ventricular Dysfunction, Left.

Sponsors: Medtronic Cardiac Rhythm and Heart Failure, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Cardiology Group?

Miami Cardiology Group has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Cardiology Group conducted?

Miami Cardiology Group has 2 clinical trials on record. Their work covers Heart Failure, Congestive, Myocardial Infarction, Ventricular Dysfunction, Left.

Is Miami Cardiology Group accredited by Crixeo Health?

Miami Cardiology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Miami Cardiology Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.